Author:
Xu Peipei,Chen Baoan,Feng Jifeng,Cheng Lu,Xia Guohua,Li Yufeng,Qian Jun,Ding Jiahua,Lu Zuhong
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Rubnitz JE, Gibson B, Smith FO. Acute myeloid leukemia. Hematol Oncol Clin North Am. 2010;24:35–63.
2. American Cancer Society. Cancer facts and figures. Atlanta: American Cancer Society; 2010.
3. Büchner T, Hiddemann W, Wormann B, Loffler H, Gassmann W, Haferlach T, et al. Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group. Blood. 1999;93:4116–24.
4. Javier BM, Chuanfa G, Ivana G, Judith EK. A phase II study of timed sequential therapy of acute myelogenous leukemia (AML) for patients over the age of 60: two cycle timed sequential therapy with topotecan, ara-C and mitoxantrone in adults with poor-risk AML. Leuk Res. 2004;28:571–7.
5. Hoggart CJ, Clark TG, De Lorio M, Whittaker JC, Balding DJ. Genome-wide significance for dense SNP and resequencing data. Genet Epidemiol. 2008;32:179–85.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献